Fundraising Fox
/Companies
Sign in

Cavalry Biosciences

Founded 2021 · 17 employees on LinkedIn · 3 known investors

Find your way into Cavalry Biosciences

Sign up to see every warm intro you have to Cavalry Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cavalry Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Cavalry Biosciences is a biopharmaceutical company focused on developing medicines that leverage the body's inherent regenerative and repair mechanisms, particularly in areas of age-related disease and tissue regeneration. The company applies translational biology and drug development expertise across multiple therapeutic areas.

BiotechDeep TechLongevityMedical Devices

Founders & leadership

Cavalry Biosciences was founded in 2021 by Jan van Deursen, PhD and Nathaniel (Ned) David, PhD.

JV
Jan van Deursen, PhDCo-founder, Advisor
N(Nathaniel (Ned) David, PhD
Nathaniel (Ned) David, PhDCo-founder, ChairmanNed David holds a PhD in biomedical sciences and has a background in venture investing focused on medicines. He is co-founder and Chairman of Cavalry Biosciences, a biopharmaceutical company developing therapies that harness the body's regenerative and repair mechanisms for age-related disease and tissue regeneration.
TS
Tim StoweFounder

Investors · 3

Eshelman Ventures, LLClisted by Eshelman Ventures, LLCWilmingtonvia Fred Eshelman · inferred
Mission Biocapitallisted by Mission BiocapitalSan Francisco · $500K

How we know: Mission Biocapital's portfolio page · the VCSheet dataset · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Cavalry Biosciences do?
Cavalry Biosciences is a biopharmaceutical company focused on developing medicines that leverage the body's inherent regenerative and repair mechanisms, particularly in areas of age-related disease and tissue regeneration. The company applies translational biology and drug development expertise across multiple therapeutic areas.
Who founded Cavalry Biosciences?
Cavalry Biosciences was founded by Jan van Deursen, PhD, Nathaniel (Ned) David, PhD in 2021.
Who are Cavalry Biosciences's investors?
Cavalry Biosciences's investors include Venrock, Eshelman Ventures, LLC, Mission Biocapital.